Nanjing Vishee Medical Technology Co (SHSE:688580) 3-Year EBITDA Growth Rate : -5.80% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nanjing Vishee Medical Technology Co 3-Year EBITDA Growth Rate?

Nanjing Vishee Medical Technology Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.24.

During the past 12 months, Nanjing Vishee Medical Technology Co's average EBITDA Per Share Growth Rate was 16.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -5.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Nanjing Vishee Medical Technology Co was 85.30% per year. The lowest was -9.20% per year. And the median was 26.10% per year.

Competitive Comparison of Nanjing Vishee Medical Technology Co's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Nanjing Vishee Medical Technology Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanjing Vishee Medical Technology Co's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nanjing Vishee Medical Technology Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Nanjing Vishee Medical Technology Co's 3-Year EBITDA Growth Rate falls into.

Nanjing Vishee Medical Technology Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Nanjing Vishee Medical Technology Co (SHSE:688580) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Nanjing Vishee Medical Technology Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Nanjing Vishee Medical Technology Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanjing Vishee Medical Technology Co (SHSE:688580) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Vishee Medical Technology Co Ltd (SHSE:688580) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 19 Ningshuang Road, Building 9, Yuhuatai District, Nanjing, CHN, 210012

Website

http://www.vishee.com

Nanjing Vishee Medical Technology Co Ltd is engaged in production and sales of rehabilitation medical devices. The company's products under Pelvic floor and postpartum rehabilitation include Pelvic floor electromyography biofeedback instrument; Myotrac series biological stimulation feedback instrument; Ruiyi Series Biostimulation Feedback Apparatus; Magneuro Series Magnetic Stimulator; Female psychological rehabilitation; Neonatal electroencephalograph; Consumables; and under Mental rehabilitation include Multi-parameter biofeedback instrument; Group biofeedback; Magneuro Series Magnetic Stimulator; and Cognitive dysfunction treatment software.

Executives

Huang He	Senior management, core technical personnel
Chou Kai	Senior management, core technical personnel
Zhong Yi Qun	senior management
Chen Li Li	Directors, senior managers
Zhang Hui	senior management
Gao Fei	Core technical personnel
Lian Qing Ming	Director

Nanjing Vishee Medical Technology Co (SHSE:688580) Headlines

No Headlines